Giulio Francolini, Radiation Oncologist at Careggi University Hospital, shared a post on X about a paper he co-authored with colleagues published in Radiotherapy and Oncology:
“Re-irradiation for prostate cancer relapse after prior radiotherapy is safe and effective. A study on behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
- 54-month fup
- Low rates of severe toxicity
- BRFS: 34 months.”
Martin Zapata Laguado, Medical Oncologist and Internal Medicine Physician at the National Cancer Institute of Colombia, shared this post, adding:
“Great work by Giulio Francolini, a current option for BCR, in a common scenario post radiotherapy with a tolerable toxicity!”
Title: Re-irradiation in patients affected by prostate cancer and relapsing after previous definitive or postoperative radiotherapy. An international registry-based study on behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO). (RE-START)
Authors: Giulio Francolini, Vanessa Di Cataldo, Saverio Ciani, Barbara A Jereczek-Fossa, Giulia Marvaso, Federico Mastroleo, Eugenio Cammarreri, Daniela Alterio, Marcin Miszczyk, Wojciech Majewski, Maja Hasterok, Fabio Matrone, Alessandra Donofrio, Luca Triggiani, Vittorio Morelli, Liliana Belgioia, Elisa D’angelo, Rosario Mazzola, Rossana Ingargiola, Antonella Fontana, Alberto Cacciola, Esmeralda Scipilliti, Lilia Bardoscia, Stefano Ciccarelli, Andrea Gaetano Allegra, Filippo Alongi, Laura Masi, Raffaela Doro, Mauro Loi, Gabriele Simontacchi, Pietro Garlatti, Michele Aquilano, Niccolò Bertini, Richard K. Valicenti, Lorenzo Livi
You can read the Full Article in Radiotherapy and Oncology.
More posts featuring Giulio Francolini.